Miroculus
Miroculus, Inc. is a biotechnology company specializing in non-invasive molecular data gathering and analysis solutions. Founded in 2014 and based in San Francisco, California, Miroculus develops advanced digital microfluidic technology that automates and miniaturizes genomic protocols, such as next-generation sequencing library preparation, cell editing, and synthetic biology. The company's hands-off sample-to-answer platform provides assay flexibility and integrates seamlessly into existing workflows, enabling the detection and monitoring of diseases at the molecular level. Miroculus serves a wide range of clients, including academic institutions, genomic research centers, pharmaceuticals, biotechnology firms, and diagnostic companies, offering low-cost, accurate, and minimally invasive molecular testing tools with its proprietary cartridge-based system.
Top Regions
Top Stages
1 past transactions
Kapplex
Acquisition in 2016
Kapplex Inc. is a Toronto-based company that designs, develops, manufactures, and markets point-of-care diagnostic platforms aimed at diagnosing common infectious diseases and cancer. Established in 2012, Kapplex specializes in providing instruments and consumables for use in retail clinics, doctors' offices, urgent care units, and emergency rooms. The company's innovative technology is built on a proprietary Digital Microfluidic (DMF) platform, which simplifies and automates traditional sample preparations and analyses on a single, cost-effective chip. This advancement allows clinicians to rapidly and accurately diagnose diseases during a patient's first visit, thereby improving treatment outcomes and reducing healthcare costs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.